129 related articles for article (PubMed ID: 27803465)
1. Improvement in the Anticancer Activity of 6-Mercaptopurine via Combination with Bismuth(III).
Yang Y; Zhou S; Ouyang R; Yang Y; Tao H; Feng K; Zhang X; Xiong F; Guo N; Zong T; Cao P; Li Y; Miao Y
Chem Pharm Bull (Tokyo); 2016; 64(11):1539-1545. PubMed ID: 27803465
[TBL] [Abstract][Full Text] [Related]
2. Novel derivatives of 6-mercaptopurine: synthesis, characterization and antiproliferative activities of S-allylthio-mercaptopurines.
Miron T; Arditti F; Konstantinovski L; Rabinkov A; Mirelman D; Berrebi A; Wilchek M
Eur J Med Chem; 2009 Feb; 44(2):541-50. PubMed ID: 18467007
[TBL] [Abstract][Full Text] [Related]
3. Studies on the cytotoxicity and anticancer performance of heterocyclic hypervalent organobismuth(III) compounds.
Liu YP; Lei J; Tang LW; Peng Y; Au CT; Chen Y; Yin SF
Eur J Med Chem; 2017 Oct; 139():826-835. PubMed ID: 28865278
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine.
Saczewski F; Maruszak M; Bednarski PJ
Arch Pharm (Weinheim); 2008 Feb; 341(2):121-5. PubMed ID: 18186543
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanism.
Qi J; Liang S; Gou Y; Zhang Z; Zhou Z; Yang F; Liang H
Eur J Med Chem; 2015; 96():360-8. PubMed ID: 25899339
[TBL] [Abstract][Full Text] [Related]
6. Complexation with organometallic ruthenium pharmacophores enhances the ability of 4-anilinoquinazolines inducing apoptosis.
Zheng W; Luo Q; Lin Y; Zhao Y; Wang X; Du Z; Hao X; Yu Y; Lü S; Ji L; Li X; Yang L; Wang F
Chem Commun (Camb); 2013 Nov; 49(87):10224-6. PubMed ID: 23856988
[TBL] [Abstract][Full Text] [Related]
7. Biological evaluation of new nickel(II) metallates: Synthesis, DNA/protein binding and mitochondrial mediated apoptosis in human lung cancer cells (A549) via ROS hypergeneration and depletion of cellular antioxidant pool.
Kalaivani P; Saranya S; Poornima P; Prabhakaran R; Dallemer F; Vijaya Padma V; Natarajan K
Eur J Med Chem; 2014 Jul; 82():584-99. PubMed ID: 24946146
[TBL] [Abstract][Full Text] [Related]
8. The calcium-chelating capability of tetrahydrofuranic moieties modulates the cytotoxicity of annonaceous acetogenins.
Liaw CC; Liao WY; Chen CS; Jao SC; Wu YC; Shen CN; Wu SH
Angew Chem Int Ed Engl; 2011 Aug; 50(34):7885-91. PubMed ID: 21744442
[No Abstract] [Full Text] [Related]
9. Structures and anti-cancer properties of two binuclear copper complexes.
Qin XY; Yang LC; Le FL; Yu QQ; Sun DD; Liu YN; Liu J
Dalton Trans; 2013 Oct; 42(41):14681-4. PubMed ID: 24026617
[TBL] [Abstract][Full Text] [Related]
10. Phenolate based metallomacrocyclic xanthate complexes of Co(II)/Cu(II) and their exclusive deployment in [2 : 2] binuclear N,O-Schiff base macrocycle formation and in vitro anticancer studies.
Singh VK; Kadu R; Roy H; Raghavaiah P; Mobin SM
Dalton Trans; 2016 Jan; 45(4):1443-54. PubMed ID: 26674056
[TBL] [Abstract][Full Text] [Related]
11. A nine-coordinated bismuth(III) complex derived from pentadentate 2,6-diacetylpyridine bis((4)N-methylthiosemicarbazone): crystal structure and both in vitro and in vivo biological evaluation.
Li MX; Yang M; Niu JY; Zhang LZ; Xie SQ
Inorg Chem; 2012 Nov; 51(22):12521-6. PubMed ID: 23136979
[TBL] [Abstract][Full Text] [Related]
12. Effect of carbon chain length on biological activity of novel palladium (II) complexes.
Gao EJ; Hong Fu ; Zhu MC; Ma C; Liang SK; Zhang J; Li LF; Wang L; Li YY; Wei Jiao
Eur J Med Chem; 2014 Jul; 82():172-80. PubMed ID: 24904964
[TBL] [Abstract][Full Text] [Related]
13. Doubly chloro bridged dimeric copper(II) complex: magneto-structural correlation and anticancer activity.
Sikdar Y; Modak R; Bose D; Banerjee S; Bieńko D; Zierkiewicz W; Bieńko A; Das Saha K; Goswami S
Dalton Trans; 2015 May; 44(19):8876-88. PubMed ID: 25871579
[TBL] [Abstract][Full Text] [Related]
14. Solvent assisted formation of ruthenium(III) and ruthenium(II) hydrazone complexes in one-pot with potential in vitro cytotoxicity and enhanced LDH, NO and ROS release.
Jayanthi E; Kalaiselvi S; Padma VV; Bhuvanesh NS; Dharmaraj N
Dalton Trans; 2016 Jan; 45(4):1693-707. PubMed ID: 26699435
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.
Chen Y; Qin MY; Wu JH; Wang L; Chao H; Ji LN; Xu AL
Eur J Med Chem; 2013; 70():120-9. PubMed ID: 24141202
[TBL] [Abstract][Full Text] [Related]
16. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
Zhou XQ; Li Y; Zhang DY; Nie Y; Li ZJ; Gu W; Liu X; Tian JL; Yan SP
Eur J Med Chem; 2016 May; 114():244-56. PubMed ID: 26994692
[TBL] [Abstract][Full Text] [Related]
17. A mononuclear Cu(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine: Synthesis, crystal structure, DNA- and BSA-binding, molecular modeling, and anticancer activity against MCF-7, A-549, and HT-29 cell lines.
Anjomshoa M; Hadadzadeh H; Torkzadeh-Mahani M; Fatemi SJ; Adeli-Sardou M; Rudbari HA; Nardo VM
Eur J Med Chem; 2015; 96():66-82. PubMed ID: 25874332
[TBL] [Abstract][Full Text] [Related]
18. New titanocene derivatives with high antiproliferative activity against breast cancer cells.
Saturnino C; Sirignano E; Botta A; Sinicropi MS; Caruso A; Pisano A; Lappano R; Maggiolini M; Longo P
Bioorg Med Chem Lett; 2014 Jan; 24(1):136-40. PubMed ID: 24332626
[TBL] [Abstract][Full Text] [Related]
19. Cancer cell cytotoxicity of cyclometalated compounds obtained with osmium(II) complexes.
Boff B; Gaiddon C; Pfeffer M
Inorg Chem; 2013 Mar; 52(5):2705-15. PubMed ID: 23427955
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, structure and in vitro pharmacological evaluation of a novel 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (2'-methylbenzoyl) hydrazone bridged copper(II) coordination polymer.
Senthil Raja D; Ramachandran E; Bhuvanesh NS; Natarajan K
Eur J Med Chem; 2013 Jun; 64():148-59. PubMed ID: 23644198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
